Trials / Completed
CompletedNCT07183735
A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Beam · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | BEAM Dream Powder | A powdered sleep supplement. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 3-6. |
| DIETARY_SUPPLEMENT | Placebo Control | A powdered placebo product. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 1-2. |
Timeline
- Start date
- 2024-07-02
- Primary completion
- 2024-10-17
- Completion
- 2024-10-17
- First posted
- 2025-09-19
- Last updated
- 2025-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07183735. Inclusion in this directory is not an endorsement.